JSAM
IMCR icon

J. Safra Asset Management’s Immunocore IMCR Stock Holding History

J. Safra Asset Management’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.84K Buy
227
+152
+203% +$4.92K ﹤0.01% 416
2025
Q4 		$2.6K Hold
75
– – ﹤0.01% 517
2025
Q3 		$2.73K Hold
75
– – ﹤0.01% 363
2025
Q2 		$2.35K Buy
+75
New +$2.33K ﹤0.01% 346
2025
Q1 		– Sell
-5
Closed -$145 – 367
2024
Q4 		$145 Hold
5
– – ﹤0.01% 339
2024
Q3 		$157 Buy
+5
New +$182 ﹤0.01% 298

Other funds holding IMCR

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

J. Safra Asset Management's IMCR Position: Q1 2026 in Review

J. Safra Asset Management increased its Immunocore (IMCR) stake by 203% in Q1 2026, buying an estimated $4.92K and bringing the position to 227 shares worth $6.84K. The position accounts for ﹤0.01% of the portfolio, ranked #416.

J. Safra Asset Management first reported a position in IMCR in Q3 2024 and has held it in 6 quarters since. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

  • J. Safra Asset Management held 227 shares of Immunocore worth $6.84K as of Q1 2026.
  • J. Safra Asset Management bought 152 Immunocore shares in Q1 2026, an estimated $4.92K.
  • Immunocore made up ﹤0.01% of J. Safra Asset Management's portfolio in Q1 2026, its #416 holding.
  • J. Safra Asset Management first reported a position in Immunocore in Q3 2024 and has held it in 6 quarters since.
  • 142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on J. Safra Asset Management's 13F filing for Q1 2026, filed 4 May 2026.